RasGRP3介导GNAQ突变型葡萄膜黑色素瘤中的MAPK信号通路激活。
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma.
作者信息
Chen Xu, Wu Qiuxia, Depeille Philippe, Chen Peirong, Thornton Sophie, Kalirai Helen, Coupland Sarah E, Roose Jeroen P, Bastian Boris C
机构信息
Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA.
Departments of Dermatology and Pathology, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA 94143, USA.
出版信息
Cancer Cell. 2017 May 8;31(5):685-696.e6. doi: 10.1016/j.ccell.2017.04.002.
Abstract
Constitutive activation of Gαq signaling by mutations in GNAQ or GNA11 occurs in over 80% of uveal melanomas (UMs) and activates MAPK. Protein kinase C (PKC) has been implicated as a link, but the mechanistic details remained unclear. We identified PKC δ and ɛ as required and sufficient to activate MAPK in GNAQ mutant melanomas. MAPK activation depends on Ras and is caused by RasGRP3, which is significantly and selectively overexpressed in response to GNAQ/11 mutation in UM. RasGRP3 activation occurs via PKC δ- and ɛ-dependent phosphorylation and PKC-independent, DAG-mediated membrane recruitment, possibly explaining the limited effect of PKC inhibitors to durably suppress MAPK in UM. The findings nominate RasGRP3 as a therapeutic target for cancers driven by oncogenic GNAQ/11.
摘要
GNAQ或GNA11突变导致的Gαq信号通路组成性激活在超过80%的葡萄膜黑色素瘤（UM）中发生，并激活丝裂原活化蛋白激酶（MAPK）。蛋白激酶C（PKC）被认为是一个关联因素，但具体机制细节仍不清楚。我们确定PKCδ和ɛ是激活GNAQ突变黑色素瘤中MAPK所必需且足够的。MAPK激活依赖于Ras，并且由RasGRP3引起，RasGRP3在UM中因GNAQ/11突变而显著且选择性地过表达。RasGRP3激活通过PKCδ和ɛ依赖性磷酸化以及不依赖PKC的二酰基甘油（DAG）介导的膜募集发生，这可能解释了PKC抑制剂对持久抑制UM中MAPK的作用有限。这些发现将RasGRP3确定为致癌性GNAQ/11驱动的癌症的治疗靶点。
相似文献
1
RasGRP3 Mediates MAPK Pathway Activation in GNAQ Mutant Uveal Melanoma.RasGRP3介导GNAQ突变型葡萄膜黑色素瘤中的MAPK信号通路激活。
Cancer Cell. 2017 May 8;31(5):685-696.e6. doi: 10.1016/j.ccell.2017.04.002.
2
Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.联合抑制蛋白激酶C和丝裂原活化蛋白激酶激酶在伴有GNAQ和GNA11突变的葡萄膜黑色素瘤中的作用
Oncogene. 2014 Sep 25;33(39):4724-34. doi: 10.1038/onc.2013.418. Epub 2013 Oct 21.
3
The protein kinase C inhibitor enzastaurin exhibits antitumor activity against uveal melanoma.蛋白激酶 C 抑制剂恩扎司琼对葡萄膜黑色素瘤具有抗肿瘤活性。
PLoS One. 2012;7(1):e29622. doi: 10.1371/journal.pone.0029622. Epub 2012 Jan 12.
4
Protein kinase C inhibitor AEB071 targets ocular melanoma harboring GNAQ mutations via effects on the PKC/Erk1/2 and PKC/NF-κB pathways.蛋白激酶 C 抑制剂 AEB071 通过影响 PKC/Erk1/2 和 PKC/NF-κB 通路靶向携带 GNAQ 突变的眼黑素瘤。
Mol Cancer Ther. 2012 Sep;11(9):1905-14. doi: 10.1158/1535-7163.MCT-12-0121. Epub 2012 May 31.
5
Heterogeneity in Mitogen-Activated Protein Kinase (MAPK) Pathway Activation in Uveal Melanoma With Somatic GNAQ and GNA11 Mutations.伴有 GNAQ 和 GNA11 体细胞突变的葡萄膜黑色素瘤中丝裂原活化蛋白激酶（MAPK）通路激活的异质性。
Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2474-2480. doi: 10.1167/iovs.18-26452.
6
Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.联合使用小分子 MEK 和 PI3K 抑制剂可增强依赖突变 GNAQ 和 GNA11 的葡萄膜黑色素瘤细胞死亡。
Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
7
The phosphoinositide 3-kinase α selective inhibitor BYL719 enhances the effect of the protein kinase C inhibitor AEB071 in GNAQ/GNA11-mutant uveal melanoma cells.磷酸肌醇 3-激酶 α 选择性抑制剂 BYL719 增强蛋白激酶 C 抑制剂 AEB071 在 GNAQ/GNA11 突变性葡萄膜黑素瘤细胞中的作用。
Mol Cancer Ther. 2014 May;13(5):1044-53. doi: 10.1158/1535-7163.MCT-13-0550. Epub 2014 Feb 21.
8
Chloroquine Sensitizes -mutated Melanoma to MEK1/2 Inhibition.氯喹使 -mutated 黑色素瘤对 MEK1/2 抑制敏感。
Clin Cancer Res. 2020 Dec 1;26(23):6374-6386. doi: 10.1158/1078-0432.CCR-20-1675. Epub 2020 Sep 15.
9
Impact of combined mTOR and MEK inhibition in uveal melanoma is driven by tumor genotype.联合 mTOR 和 MEK 抑制对葡萄膜黑色素瘤的影响取决于肿瘤基因型。
PLoS One. 2012;7(7):e40439. doi: 10.1371/journal.pone.0040439. Epub 2012 Jul 10.
10
Identification of unique MEK-dependent genes in GNAQ mutant uveal melanoma involved in cell growth, tumor cell invasion, and MEK resistance.鉴定 GNAQ 突变性葡萄膜黑色素瘤中独特的 MEK 依赖性基因，这些基因涉及细胞生长、肿瘤细胞侵袭和 MEK 耐药性。
Clin Cancer Res. 2012 Jul 1;18(13):3552-61. doi: 10.1158/1078-0432.CCR-11-3086. Epub 2012 May 1.
引用本文的文献
1
CRISPR-Cas13d-Mediated Targeting of a Context-Specific Essential Gene Enables Selective Elimination of Uveal Melanoma.CRISPR-Cas13d介导的特定背景必需基因靶向实现葡萄膜黑色素瘤的选择性消除。
bioRxiv. 2025 Aug 21:2025.08.21.671629. doi: 10.1101/2025.08.21.671629.
2
GDF15 reprograms the microenvironment to drive the development of uveal melanoma liver metastases.生长分化因子15（GDF15）重塑微环境以驱动葡萄膜黑色素瘤肝转移的发展。
bioRxiv. 2025 May 10:2025.05.07.652654. doi: 10.1101/2025.05.07.652654.
3
Super-enhancers orchestrate transcriptional dysregulation and metabolic reprogramming in uveal melanoma.超级增强子在葡萄膜黑色素瘤中协调转录失调和代谢重编程。
Commun Biol. 2025 Jun 23;8(1):951. doi: 10.1038/s42003-025-08338-8.
4
The guanine nucleotide exchange factor Ric-8A regulates the sensitivity of constitutively active Gαq to the inhibitor YM-254890.鸟嘌呤核苷酸交换因子Ric-8A调节组成型活性Gαq对抑制剂YM-254890的敏感性。
J Biol Chem. 2025 Mar 19;301(5):108426. doi: 10.1016/j.jbc.2025.108426.
5
Loss of NF1 Accelerates Uveal and Intradermal Melanoma Tumorigenesis, and Oncogenic GNAQ Transforms Schwann Cells.神经纤维瘤蛋白1缺失加速葡萄膜和皮内黑色素瘤的肿瘤发生，且致癌性GNAQ可转化雪旺细胞。
Cancer Res Commun. 2025 Feb 1;5(2):209-225. doi: 10.1158/2767-9764.CRC-24-0386.
6
PDGFR-α shRNA-polyplex for uveal melanoma treatment via EMT mediated vasculogenic mimicry interfering.通过干扰EMT介导的血管生成拟态来治疗葡萄膜黑色素瘤的血小板衍生生长因子受体α短发夹RNA多聚体
J Nanobiotechnology. 2024 Dec 26;22(1):797. doi: 10.1186/s12951-024-03077-0.
7
GNAQ/GNA11-Related Benign and Malignant Entities-A Common Histoembriologic Origin or a Tissue-Dependent Coincidence.与GNAQ/GNA11相关的良性和恶性病变——共同的组织胚胎学起源还是组织依赖性巧合？
Cancers (Basel). 2024 Oct 30;16(21):3672. doi: 10.3390/cancers16213672.
8
Neuropeptide Precursor VGF Promotes Liver Metastatic Colonization of Gαq Mutant Uveal Melanoma by Facilitating Tumor Microenvironment via Paracrine Loops.神经肽前体VGF通过旁分泌环促进肿瘤微环境，从而促进Gαq突变型葡萄膜黑色素瘤的肝转移定植。
Adv Sci (Weinh). 2024 Dec;11(46):e2407967. doi: 10.1002/advs.202407967. Epub 2024 Oct 18.
9
A review and perspective paper: Ras oncogene gets modest, from kingpin to mere henchman.综述与观点论文：Ras 癌基因从主谋到小喽啰。
Cell Mol Life Sci. 2024 Oct 1;81(1):412. doi: 10.1007/s00018-024-05449-z.
10
The role of signaling pathways mediated by the GPCRs CysLTR1/2 in melanocyte proliferation and senescence.GPCRs CysLTR1/2 介导的信号通路在黑素细胞增殖和衰老中的作用。
Sci Signal. 2024 Sep 17;17(854):eadp3967. doi: 10.1126/scisignal.adp3967.
本文引用的文献
1
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma.葡萄膜黑色素瘤中G蛋白偶联受体CYSLTR2的复发性激活突变。
Nat Genet. 2016 Jun;48(6):675-80. doi: 10.1038/ng.3549. Epub 2016 Apr 18.
2
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4.葡萄膜黑色素瘤的深度测序确定了PLCB4基因中的一个复发性突变。
Oncotarget. 2016 Jan 26;7(4):4624-31. doi: 10.18632/oncotarget.6614.
3
Mutant Gq/11 promote uveal melanoma tumorigenesis by activating YAP.突变 Gq/11 通过激活 YAP 促进葡萄膜黑色素瘤的发生。
Cancer Cell. 2014 Jun 16;25(6):822-30. doi: 10.1016/j.ccr.2014.04.017. Epub 2014 May 29.
4
Hippo-independent activation of YAP by the GNAQ uveal melanoma oncogene through a trio-regulated rho GTPase signaling circuitry.GNAQ 葡萄膜黑素瘤癌基因通过 trio 调控的 rho GTP 酶信号通路非 Hippo 依赖性激活 YAP。
Cancer Cell. 2014 Jun 16;25(6):831-45. doi: 10.1016/j.ccr.2014.04.016. Epub 2014 May 29.
5
Function of RasGRP3 in the formation and progression of human breast cancer.RasGRP3在人类乳腺癌形成和进展中的作用。
Mol Cancer. 2014 Apr 29;13:96. doi: 10.1186/1476-4598-13-96.
6
RasGRP Ras guanine nucleotide exchange factors in cancer.癌症中的Ras鸟嘌呤核苷酸交换因子RasGRP
Front Biol (Beijing). 2013 Oct 1;8(5):508-532. doi: 10.1007/s11515-013-1276-9.
7
Combined PKC and MEK inhibition in uveal melanoma with GNAQ and GNA11 mutations.联合抑制蛋白激酶C和丝裂原活化蛋白激酶激酶在伴有GNAQ和GNA11突变的葡萄膜黑色素瘤中的作用
Oncogene. 2014 Sep 25;33(39):4724-34. doi: 10.1038/onc.2013.418. Epub 2013 Oct 21.
8
Single nucleotide polymorphism array analysis of uveal melanomas reveals that amplification of CNKSR3 is correlated with improved patient survival.单核苷酸多态性微阵列分析葡萄膜黑色素瘤显示，CNKSR3 的扩增与改善患者的生存相关。
Am J Pathol. 2013 Mar;182(3):678-87. doi: 10.1016/j.ajpath.2012.11.036. Epub 2013 Jan 26.
9
Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations.BRAF V600 突变型黑色素瘤的联合 BRAF 和 MEK 抑制治疗。
N Engl J Med. 2012 Nov 1;367(18):1694-703. doi: 10.1056/NEJMoa1210093. Epub 2012 Sep 29.
10
Combination small molecule MEK and PI3K inhibition enhances uveal melanoma cell death in a mutant GNAQ- and GNA11-dependent manner.联合使用小分子 MEK 和 PI3K 抑制剂可增强依赖突变 GNAQ 和 GNA11 的葡萄膜黑色素瘤细胞死亡。
Clin Cancer Res. 2012 Aug 15;18(16):4345-55. doi: 10.1158/1078-0432.CCR-11-3227. Epub 2012 Jun 25.
Zotero 插件